Suppr超能文献

[影响胰腺导管腺癌根治性切除术后复发和转移的因素分析]

[Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma].

作者信息

Xie Yi-Bin, Zhao Ping, Wang Cheng-Feng, Shan Yi, Zhao Dong-Bing, Liu Qian, Bai Xiao-Feng

机构信息

Department of Abdominal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):686-9.

Abstract

OBJECTIVE

To investigate the factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma and analyze the prognosis.

METHODS

The clinicopathological and follow-up data of 56 patients who underwent curative resection for pancreatic ductal adenocarcinoma between Jan. 1997 and Dec. 2006 in this hospital were analyzed retrospectively.

RESULTS

The recurrence rate after curative resection was 73.2% (41/56). The recurrence rate after operation at the time of 3 months, half year, 1 year and 2 years was 26.8% (15/56), 51.8% (29/56), 64.3% (36/56) and 69.6% (39/56), respectively. Hepatic metastasis and local recurrence accounted for 36.6% and 31.7% of the cases, respectively. The 3-year accumulated survival of this group was 22.7%. The symptom presenting time, back pain, preoperative level of CA19-9, tumor size, AJCC stage and T stage were correlated with metastasis/recurrence. Univariate analysis revealed that the preoperative level of CA19-9, T stage and the tumor size were prognostic factors. Cox regression analysis revealed that only tumor size was an independent prognostic factor.

CONCLUSION

The metastasis or recurrence mostly occurs within 2 years after curative resection, and the liver is the most common site of metastasis. High recurrence rate is the major reason causing the failure of curative resection and short survival time after operation. The symptom presenting time, back pain, preoperative level of CA19-9, tumor size, AJCC stage and T stage are correlated with metastasis/recurrence. The tumor size is an independent prognostic factor.

摘要

目的

探讨影响胰腺导管腺癌根治性切除术后复发和转移的因素,并分析预后情况。

方法

回顾性分析1997年1月至2006年12月在本院接受胰腺导管腺癌根治性切除的56例患者的临床病理及随访资料。

结果

根治性切除术后复发率为73.2%(41/56)。术后3个月、半年、1年和2年的复发率分别为26.8%(15/56)、51.8%(29/56)、64.3%(36/56)和69.6%(39/56)。肝转移和局部复发分别占病例的36.6%和31.7%。该组患者3年累积生存率为22.7%。症状出现时间、背痛、术前CA19-9水平、肿瘤大小、美国癌症联合委员会(AJCC)分期和T分期与转移/复发相关。单因素分析显示术前CA19-9水平、T分期和肿瘤大小是预后因素。Cox回归分析显示只有肿瘤大小是独立的预后因素。

结论

根治性切除术后转移或复发大多发生在2年内,肝脏是最常见的转移部位。高复发率是导致根治性切除失败和术后生存时间短的主要原因。症状出现时间、背痛、术前CA19-9水平、肿瘤大小、AJCC分期和T分期与转移/复发相关。肿瘤大小是独立的预后因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验